Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01681433
Title OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Costantine Albany
Age Groups: adult
Covered Countries USA | CAN

No variant requirements are available.